Full Text
Budget Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in Specialties Hospital In Ecuador

Abstract

Authors

P Irigoyen A Moreno C Gavilanes

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×